Raffles Medical Group Ltd, commonly referred to as RMG, is a leading integrated healthcare provider headquartered in Singapore (SG). Established in 1976, the company has grown significantly, expanding its operations across Asia, including key markets in China and Vietnam.
Operating within the healthcare industry, Raffles Medical Group offers a comprehensive range of services, including primary care, specialist consultations, and hospital services. Its unique approach combines advanced medical technology with patient-centric care, setting it apart in a competitive landscape.
Recognised for its commitment to quality, RMG has achieved notable milestones, including the establishment of Raffles Hospital, which is a flagship facility in Singapore. With a strong market position, Raffles Medical Group continues to be a trusted name in healthcare, dedicated to enhancing the well-being of its patients through innovative solutions and exceptional service.
+5 vs industry average
Raffles Medical Group Ltd’s score of 27 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Raffles Medical Group Ltd?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has increased its overall emissions by 7% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Raffles Medical Group Ltd's reported carbon emissions
In 2024, Raffles Medical Group Ltd reported total carbon emissions of approximately 18,197,000 kg CO2e. This figure includes Scope 1 emissions of about 1,198,000 kg CO2e and Scope 2 emissions of approximately 17,000,000 kg CO2e. The company has not disclosed any Scope 3 emissions data. Raffles Medical Group has set ambitious climate commitments, aiming for a long-term reduction of 10% in both Scope 1 and Scope 2 emissions by 2050, with a medium-term target of a 5% reduction by 2030. Additionally, they are targeting a 5% reduction in energy consumption intensity by 2035 and a similar reduction in waste generation intensity by 2030. As a current subsidiary of Raffles Medical Group Ltd, the emissions data is directly sourced from their own reporting, ensuring accuracy and relevance to their climate initiatives. The company is actively working towards these targets, demonstrating a commitment to sustainability and environmental responsibility.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Raffles Medical Group Ltd’s Climate Goals (2030 & 2050)
6 goals2050
10% reduction in Scope 2
Long-term: Reduce levels of Scope 1 and Scope 2 emissions by 10%.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 6 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Raffles Medical Group Ltd
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project